Stage III Uveal Melanoma AJCC v7
3 clinical trials · Condition
◉ Watch Stage III Uveal Melanoma AJCC v7
| Record | Firm | Date |
|---|---|---|
| Glembatumumab Vedotin, Nivolumab, and Ipilimumab in Treating Patients With Advanced Metastatic Solid Tumors That Cannot Be Removed by Surgery (NCT03326258) | National Cancer Institute (NCI) | 2018-04-20 |
| Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma (NCT02068586) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2014-11-19 |
| Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed by Surgery (NCT01835145) | National Cancer Institute (NCI) | 2013-07-31 |
Track Stage III Uveal Melanoma AJCC v7 automatically
Every clearance here is in the API, with alerts when new ones post.